Search clinical trials for: RUTI® Vaccine

Total 19574 results

Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute Ltd

Not yet recruiting

Covid-19 and Influenza Oral Vaccine Study

Influenza, Human | covid19 Infection

Australia
Pfizer

Recruiting

A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.

Chlamydia | Gonorrhea | Meningococcal Vaccines

United States
Merete Haedersdal

Active, not recruiting

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients With Actinic Keratosis (VAXAK)

Actinic Keratoses | Basal Cell Carcinoma | Squamous Cell Carcinoma

Denmark
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1

Breast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein Overexpression

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children

Parainfluenza Virus 3, Human

United States, Puerto Rico
Sichuan University

Not yet recruiting

A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC

Esophageal Squamous Cell Carcinoma

China
Centers for Disease Control and Prevention
Ministry of Health, Thailand

Completed

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

Influenza

Thailand
Hong Kong Sanatorium & Hospital

Completed

Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong

Covid-19 Vaccine

Hong Kong
Bharat Biotech International Limited

Active, not recruiting

A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131). (Hillchol)

Cholera

India
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart

Dengue

United States
Nabi Biopharmaceuticals
National Institute on Drug Abuse (NIDA)

Completed

NicVAX/Placebo as an Aid for Smoking Cessation

Smoking | Smoking Cessation | Tobacco Cessation

United States
TD Vaccines A/S
Johns Hopkins University; Pierrel Research USA, Inc.

Completed

ACE527 Safety and Immunogenicity Study

Enterotoxigenic E. Coli (ETEC) Infection

United States
French National Agency for Research on AIDS and...
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

HIV Infections
Novavax

Completed

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Covid19 | SARS-CoV Infection

Australia
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers (MET41)

Healthy Volunteers (Meningococcal Infection)

Puerto Rico, United States
Clifford Craig Medical Research Trust
Johns Hopkins Bloomberg School of Public Health; Monash University; University... and other collaborators

Unknown

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

Heterologous Effects of Vaccines

Australia
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

Influenza

United States, Canada, Mexico
Laval University

Completed

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Human Papillomavirus

Canada
Partha Basu
All India Institute of Medical Sciences, New Delhi; Tata Memorial Centre; Deutsches... and other collaborators

Active, not recruiting

Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India

Cervical Cancer | Cervical Precancerous Lesions

India
Hualan Biological Bacterin Co. Ltd.
Henan Center for Disease Control and Prevention

Completed

To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell) (rabies)

Rabies Human

China
Xiamen Innovax Biotech Co., Ltd

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)

Hepatitis B | Hepatitis E

China
Nabi Biopharmaceuticals

Completed

A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation

Smoking Cessation

United States
Govind Ballabh Pant Hospital
Indian Council of Medical Research; Lady Hardinge Medical College

Completed

Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers

Chronic Hepatitis B

India
Novartis
Novartis Vaccines

Completed

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Japanese Encephalitis | Rabies | Yellow Fever | Meningococcal Disease | Typhoid | Meningococcal Meningitis

Czech Republic, Germany
Mahidol University
World Health Organization; The Government Pharmaceutical Organization

Completed

Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine

Avian Influenza

Thailand
NanoPass Technologies Ltd

Completed

A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines (NANOVAX)

Influenza, Human
London School of Hygiene and Tropical Medicine
National Institute for Medical Research, Tanzania; Ocean Road Cancer Institute... and other collaborators

Completed

Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls

Cervical Cancer

Tanzania
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Influenza

United States
PATH

Completed

Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults

Polio

Belgium
University of Oxford
KEMRI-Wellcome Trust Collaborative Research Program

Completed

A Trial of n-3 PUFA-Enriched Ready to Use Therapeutic Food for Childhood Severe Malnutrition (Njugu Plus)

Severe Acute Malnutrition

Kenya
Assistance Publique - Hôpitaux de Paris

Completed

Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings (PACIFIC)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia

France
University of Oxford
KEMRI-Wellcome Trust Collaborative Research Program

Completed

Gonococcal Vaccine Study in Key Populations in Kenya (BexKPK)

Gonorrhea

Kenya
Sanofi Pasteur, a Sanofi Company
United States Department of Defense

Completed

Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine

Dengue | Dengue Fever | Dengue Hemorrhagic Fever

United States
Edward Hirschowitz
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer

Lung Cancer

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Meningitis | Meningococcal Infections | Meningococcal Meningitis | Invasive Meningococcal Disease

United States
ImmunityBio, Inc.

Terminated

THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines

COVID-19

South Africa
National Vaccine and Serum Institute, China
Beijing Institute of Biological Products Co Ltd.; Lanzhou Institute of Biological...

Active, not recruiting

Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above

COVID-19 Pneumonia

China
Jiangsu Province Centers for Disease Control and...

Completed

Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese

Vaccine
MCM Vaccines B.V.

Completed

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Virus Diseases | Bacterial Infections | Neisseria Meningitidis
Sanofi Pasteur, a Sanofi Company

Completed

A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study

Meningococcal Immunization
Sinovac Research and Development Co., Ltd.

Withdrawn

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

COVID-19

China
Insight Therapeutics, LLC
Brown University

Completed

High Dose Influenza Vaccine in Nursing Home - Pilot Study

Influenza

United States
Pfizer

Completed

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults (CAPITA)

Pneumococcal Infections | Pneumonia, Pneumococcal | 13-valent Pneumococcal Vaccine

Netherlands
University of Rochester
National Institutes of Health (NIH); Dartmouth-Hitchcock Medical Center

Completed

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Influenza

United States
Giselle Guerra

Terminated

COVID-19 3rd Dose Vaccine in Transplant Patients

Covid19

United States
University of Witwatersrand, South Africa
Merck Sharp & Dohme LLC

Completed

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Cervical High Grade Squamous Intraepithelial Lesion
GlaxoSmithKline

Completed

Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old

AIDS

Germany
Butantan Institute

Completed

Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute (FLU-05-IB)

Influenza Vaccines

Brazil
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States

Search clinical trials for: RUTI® Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations